Lymphedema and therapeutic lymphangiogenesis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Saito, Yukihiro ^a   Nakagami, Hironori ^b   Kaneda, Yasufumi ^c   Morishita, Ryuichi ^c  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; RAS PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SOX18; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

BREAST CANCER; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 15; COMPRESSION BANDAGE; DISEASE EXACERBATION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; KAPOSI SARCOMA; KLINEFELTER SYNDROME; LIPID ABSORPTION; LIPID STORAGE; LYMPHANGIOGENESIS; LYMPHEDEMA; LYMPHOMA; MACROPHAGE; MASSAGE; MONOCYTE; NONHUMAN; NOONAN SYNDROME; PHYSIOTHERAPY; REVIEW; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS TISSUE; TRISOMY; TURNER SYNDROME; UPREGULATION; ANIMAL; DISEASE MODEL; EDEMA; ENDOTHELIUM CELL; GENETICS; LYMPH VESSEL; METABOLISM; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; EDEMA; ENDOTHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHEDEMA;

EID: 84886472241     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/804675     Document Type: Review

References (47)

1. Witte M. H., Bernas M. J., Martin C. P., Witte C. L., Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microscopy Research and Technique 2001 55 2 122 145 2-s2.0-0035886703 10.1002/jemt.1163 (Pubitemid 32988912)
2. Oliver G., Detmar M., The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes and Development 2002 16 7 773 783 2-s2.0-0036208217 10.1101/gad.975002 (Pubitemid 34280101)
3. Jeltsch M., Tammela T., Alitalo K., Wilting J., Genesis and pathogenesis of lymphatic vessels. Cell and Tissue Research 2003 314 1 69 84 2-s2.0-0242488987 10.1007/s00441-003-0777-2 (Pubitemid 37409914)
4. Küchler A. M., Gjini E., Peterson-Maduro J., Cancilla B., Wolburg H., Schulte-Merker S., Development of the zebrafish lymphatic system requires Vegfc signaling. Current Biology 2006 16 12 1244 1248 2-s2.0-33744996035 10.1016/j.cub.2006.05.026 (Pubitemid 43867297)
5. Ny A., Koch M., Schneider M., Neven E., Tong R. T., Maity S., Fischer C., Plaisance S., Lambrechts D., Héligon C., Terclavers S., Ciesiolka M., Kälin R., Wing Y. M., Senn I., Wyns S., Lupu F., Brändli A., Vleminckx K., Collen D., Dewerchin M., Conway E. M., Moons L., Jain R. K., Carmeliet P., A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nature Medicine 2005 11 9 998 1004 2-s2.0-24744449289 10.1038/nm1285 (Pubitemid 41294447)
6. Yaniv K., Isogai S., Castranova D., Dye L., Hitomi J., Weinstein B. M., Live imaging of lymphatic development in the zebrafish. Nature Medicine 2006 12 6 711 716 2-s2.0-33744967506 10.1038/nm1427 (Pubitemid 43865243)
7. De Almeida A. B., Freedman D. O., Epidemiology and immunopathology of bancroftian filariasis. Microbes and Infection 1999 1 12 1015 1022 2-s2.0-0032717013 10.1016/S1286-4579(99)80519-X
8. Szuba A., Rockson S. G., Lymphedema: classification, diagnosis and therapy. Vascular Medicine 1998 3 2 145 156 2-s2.0-0031726017 (Pubitemid 28481265)
9. Kurland L. T., Molgaard C. A., The patient record in epidemiology. Scientific American 1981 245 4 54 63 2-s2.0-0019624218
10. Smeltzer D. M., Stickler G. B., Schirger A., Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985 76 2 206 218 2-s2.0-0021799963 (Pubitemid 15039904)
11. DiSipio T., Rye S., Newman B., Hayes S., Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. The Lancet Oncology 2013 14 6 500 515
12. Ohba Y., Todo Y., Kobayashi N., Kaneuchi M., Watari H., Takeda M., Sudo S., Kudo M., Kato H., Sakuragi N., Risk factors for lower-limb lymphedema after surgery for cervical cancer. International Journal of Clinical Oncology 2011 16 3 238 243 2-s2.0-80052776117 10.1007/s10147-010-0171-5
13. Tada H., Teramukai S., Fukushima M., Sasaki H., Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer 2009 9, article 47 2-s2.0-63549089155 10.1186/1471-2407-9-47
14. Beesley V., Janda M., Eakin E., Obermair A., Battistutta D., Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 2007 109 12 2607 2614 2-s2.0-34250195758 10.1002/cncr.22684 (Pubitemid 46906482)
15. Cormier J. N., Askew R. L., Mungovan K. S., Xing Y., Ross M. I., Armer J. M., Lymphedema beyond breast cancer. Cancer 2010 116 22 5138 5149 2-s2.0-78449283134 10.1002/cncr.25458
16. Ko D. S. C., Lerner R., Klose G., Cosimi A. B., Effective treatment of lymphedema of the extremities. Archives of Surgery 1998 133 4 452 458 2-s2.0-0031921358 10.1001/archsurg.133.4.452 (Pubitemid 28193533)
17. Girgis A., Stacey F., Lee T., Black D., Kilbreath S., Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study. BMJ 2011 342 d3442 2-s2.0-80555154995 10.1136/bmj.d3442
18. International Society of Lymphology, The diagnosis and treatment of peripheral lymphedema. Lymphology 2009 42 2 51 60
19. Maher T. M., Wells A. U., Laurent G. J., Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? European Respiratory Journal 2007 30 5 835 839 2-s2.0-38849178850 10.1183/09031936.00069307 (Pubitemid 351194784)
20. Harvey N. L., Srinivasan R. S., Dillard M. E., Johnson N. C., Witte M. H., Boyd K., Sleeman M. W., Oliver G., Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nature Genetics 2005 37 10 1072 1081 2-s2.0-27144478129 10.1038/ng1642 (Pubitemid 41486659)
21. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. Journal of Biological Chemistry 2006 281 36 26602 26614 2-s2.0-33748750917 10.1074/jbc.M601284200 (Pubitemid 44401869)
22. Suganami T., Ogawa Y., Adipose tissue macrophages: their role in adipose tissue remodeling. Journal of Leukocyte Biology 2010 88 1 33 39 2-s2.0-77954672503 10.1189/jlb.0210072
23. Cueni L. N., Detmar M., New insights into the molecular control of the lymphatic vascular system and its role in disease. Journal of Investigative Dermatology 2006 126 10 2167 2177 2-s2.0-33748771724 10.1038/sj.jid.5700464 (Pubitemid 44413162)
24. Karpanen T., Alitalo K., Molecular biology and pathology of lymphangiogenesis. Annual Review of Pathology 2008 3 367 397 2-s2.0-41749093830 10.1146/annurev.pathmechdis.3.121806.151515 (Pubitemid 351488286)
25. Stewart F. W., Treves N., Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948 1 1 64 81 2-s2.0-0019609313
26. Heitmann C., Ingianni G., Stewart-Treves syndrome: lymphangiosarcoma following mastectomy. Annals of Plastic Surgery 2000 44 1 72 75 2-s2.0-0033958772 (Pubitemid 30056300)
27. Jussila L., Alitalo K., Vascular growth factors and lymphangiogenesis. Physiological Reviews 2002 82 3 673 700 2-s2.0-0036306121 (Pubitemid 34743335)
28. Karkkainen M. J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T. V., Jeltsch M., Jackson D. G., Talikka M., Rauvala H., Betsholtz C., Alitalo K., Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 2004 5 1 74 80 2-s2.0-9144236286 10.1038/ni1013 (Pubitemid 38081471)
29. Mäkinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M. I., Pulkkanen K. J., Kauppinen R., Jackson D. G., Kubo H., Nishikawa S.-I., Ylä-Herttuala S., Alitalo K., Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nature Medicine 2001 7 2 199 205 2-s2.0-0035122695 10.1038/84651 (Pubitemid 32148487)
30. Yoon Y.-S., Murayama T., Gravereaux E., Tkebuchava T., Silver M., Curry C., Wecker A., Kirchmair R., Hu C. S., Kearney M., Ashare A., Jackson D. G., Kubo H., Isner J. M., Losordo D. W., VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. Journal of Clinical Investigation 2003 111 5 717 725 2-s2.0-0037373489 10.1172/JCI200315830 (Pubitemid 36278590)
31. Morisada T., Oike Y., Yamada Y., Urano T., Akao M., Kubota Y., Maekawa H., Kimura Y., Ohmura M., Miyamoto T., Nozawa S., Koh G. Y., Alitalo K., Suda T., Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 2005 105 12 4649 4656 2-s2.0-20444414142 10.1182/blood-2004-08-3382 (Pubitemid 40807284)
32. Chang L. K., Garcia-Cardeña G., Farnebo F., Fannon M., Chen E. J., Butterfield C., Moses M. A., Mulligan R. C., Folkman J., Kaipainen A., Dose-dependent response of FGF-2 for lymphangiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2004 101 32 11658 11663 2-s2.0-4143121247 10.1073/pnas.0404272101 (Pubitemid 39095352)
33. Nakamura Y., Morishita R., Higaki J., Kida I., Aoki M., Moriguchi A., Yamada K., Hayashi S.-I., Yo Y., Nakano H., Matsumoto K., Nakamura T., Ogihara T., Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. Journal of Hypertension 1996 14 9 1067 1072 2-s2.0-10144241020 (Pubitemid 26329282)
34. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., Isner J. M., Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998 97 4 381 390 2-s2.0-0032477844 (Pubitemid 28074339)
35. Rappolee D. A., Iyer A., Patel Y., Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circulation Research 1996 78 6 1028 1036 2-s2.0-0029931397 (Pubitemid 26166711)
36. Taniyama Y., Morishita R., Nakagami H., Moriguchi A., Sakonjo H., Shokei-Kim S.-K., Matsumoto K., Nakamura T., Higaki J., Ogihara T., Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 2000 102 2 246 252 2-s2.0-0034636783 (Pubitemid 30451784)
37. Jung W., Castren E., Odenthal M., Vande Woude G. F., Ishii T., Dienes H.-P., Lindholm D., Schirmacher P., Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. Journal of Cell Biology 1994 126 2 485 494 2-s2.0-0028308229 10.1083/jcb.126.2.485 (Pubitemid 24226264)
38. Taniyama Y., Morishita R., Aoki M., Hiraoka K., Yamasaki K., Hashiya N., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T., Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002 40 1 47 53 2-s2.0-0036311037 10.1161/01.HYP.0000020755.56955.BF (Pubitemid 34755978)
39. Aoki M., Morishita R., Taniyama Y., Kaneda Y., Ogihara T., Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. Journal of atherosclerosis and thrombosis 2000 7 2 71 76 2-s2.0-0034577262
40. Koike H., Ishida A., Shimamura M., Mizuno S., Nakamura T., Ogihara T., Kaneda Y., Morishita R., Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease. Gene Therapy 2006 13 23 1639 1644 2-s2.0-33751181265 10.1038/sj.gt.3302810 (Pubitemid 44774208)
41. Watanabe M., Ebina M., Orson F. M., Nakamura A., Kubota K., Koinuma D., Akiyama K.-I., Maemondo M., Okouchi S., Tahara M., Matsumoto K., Nakamura T., Nukiwa T., Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Molecular Therapy 2005 12 1 58 67 2-s2.0-20844447573 10.1016/j.ymthe.2005.02.019 (Pubitemid 40862357)
42. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M., Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. Journal of Cell Biology 1992 119 3 629 641 2-s2.0-0026722243 10.1083/jcb.119.3.629
43. Graziani A., Gramaglia D., Cantley L. C., Comoglio P. M., The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. Journal of Biological Chemistry 1991 266 33 22087 22090 2-s2.0-0025788025 (Pubitemid 21908617)
44. Graziani A., Gramaglia D., Dalla Zonca P., Comoglio P. M., Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. Journal of Biological Chemistry 1993 268 13 9165 9168 2-s2.0-0027322529 (Pubitemid 23145952)
45. Saito Y., Nakagami H., Morishita R., Takami Y., Kikuchi Y., Hayashi H., Nishikawa T., Tamai K., Azuma N., Sasajima T., Kaneda Y., Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006 114 11 1177 1184 2-s2.0-33748670727 10.1161/CIRCULATIONAHA.105.602953 (Pubitemid 44386482)
46. Morishita R., Aoki M., Hashiya N., Makino H., Yamasaki K., Azuma J., Sawa Y., Matsuda H., Kaneda Y., Ogihara T., Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004 44 2 203 209 2-s2.0-3543025721 10.1161/01.HYP.0000136394. 08900.ed (Pubitemid 39014240)
47. Isner J. M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., Symes J. F., Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. The Lancet 1996 348 9024 370 374 2-s2.0-15844420661 10.1016/S0140- 6736(96)03361-2 (Pubitemid 26261511)